Brigitte Bloechl‐Daum

Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment

Brigitte Bloechl‐Daum, Robert Deuson, Panagiotis Mavros et al. · Journal of Clinical Oncology · 2006 · 497 citations

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 184 citations · Full text

Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Hans‐Georg Eichler, Brigitte Bloechl‐Daum, Karl Broich et al. · Clinical Pharmacology & Therapeutics · 2018 · 101 citations · Full text

Real-world Data, Information Poor, Data Science +22

“Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials?

H‐G Eichler, Brigitte Bloechl‐Daum, Philipp K. Bauer et al. · Clinical Pharmacology & Therapeutics · 2016 · 75 citations · Full text

Low risk pragmatic trials do not always require participants’ informed consent

Rafael Dal‐Ré, C. Avendaño, Brigitte Bloechl‐Daum et al. · BMJ · 2019 · 38 citations · Full text

Evidence-based Medicine, Law, Research Ethics +18